Evidence for Neuroprotective Effect of Sulbutiamine against Oxygen-Glucose Deprivation in Rat Hippocampal CA1 Pyramidal Neurons
- Authors
- Kwag, Jeehyun; Majid, Aman Shah Abdul; Kang, Kui Dong
- Issue Date
- Nov-2011
- Publisher
- PHARMACEUTICAL SOC JAPAN
- Keywords
- sulbutiamine; oxygen-glucose deprivation; hippocampus; neuroprotection
- Citation
- BIOLOGICAL & PHARMACEUTICAL BULLETIN, v.34, no.11, pp.1759 - 1764
- Indexed
- SCIE
SCOPUS
- Journal Title
- BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Volume
- 34
- Number
- 11
- Start Page
- 1759
- End Page
- 1764
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/111246
- ISSN
- 0918-6158
- Abstract
- Hippocampus is one of the earliest brain regions that gets affected by ischemia, however, no pharmacological therapy exists yet that can fully counteract the ischemic damage. Here we study the effect of sulbutiamine, a synthetic thiamine analogue that can cross the blood-brain barrier easily, on hippocampal neurons under an in vitro model of ischemia, oxygen-glucose deprivation (OGD). We find that exposure to OGD in the presence of sulbutiamine significantly increases neuronal viability and enhances electrophysiological properties such as excitatory synaptic transmissions and intrinsic neuronal membrane input resistance in a concentration-dependent manner. Overall, here we report, for the first time, the neuroprotective evidence of sulbutiamine on hippocampal CA1 pyramidal neurons under OGD, which may have beneficial implications as a possible therapeutic agent/substance against ischemic insult.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Graduate School > Department of Brain and Cognitive Engineering > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.